Suppr超能文献

小鼠骨髓瘤MOPC 315中改变的免疫球蛋白重链的糖基化与分泌

Glycosylation and secretion of an altered immunoglobulin heavy chain in mouse myeloma MOPC 315.

作者信息

Sonenshein G E, McCormack J

出版信息

J Immunol. 1982 Dec;129(6):2559-63.

PMID:6292292
Abstract

A variant line (LV-1) of mouse myeloma MOPC 315 (IgA, lambda 2) has lost the ability to synthesize L chain. It synthesizes an altered H chain (H' chain) that is turned over intracellularly and is not secreted. Rescue of H' chain secretion can be accomplished by fusion of LV-1 to a variant of another myeloma line, MPC 11 (IgG2b, kappa), which only synthesizes a light chain. The hybrid (X-2) secretes the H' chain in a four chain structure (kappa 2 alpha' 2). In wild-type MOPC 315 cells, it was reported previously that inhibition of core sugar addition blocks the secretion of the H chain polypeptide. We have studied glycosylation in MPOC 315 wild-type, LV-1 variant, and X-2 hybrid cell lines. The ability of all three lines to add the core sugars mannose and glucosamine to heavy chain was demonstrated. Due to the instability of the H' chain in LV-1, it is difficult to assess H' chain fucosylation directly. To study fucose addition in LV-1, the enveloped virus vesicular stomatitis (VSV), which can infect the three lines, was utilized. The fucosylation and secretion of VSV glycoprotein G was discernible in all three lines; however, only LV-1 cannot activate free fucose, and instead fucosylates through conversion of the mannose intermediate. Normal fucose addition to H chain in a wild-type cell occurred immediately before secretion. The fact that degradation of H' chain in LV-1 begins before fucosylation suggests that the rescue of H' chain secretion by formation of the X-2 hybrid is due to the acquired presence of a suitable L chain rather than complementation of a sugar defect. These observations indicate that proper assembly of the polypeptide components of some secretory proteins, e.g., Ig molecules, is required for the secretion of the individual chains.

摘要

小鼠骨髓瘤MOPC 315(IgA,λ2)的一个变异株系(LV-1)已丧失合成轻链的能力。它合成了一种改变的重链(H'链),该重链在细胞内被周转且不分泌。通过将LV-1与另一个骨髓瘤细胞系MPC 11(IgG2b,κ)的变异株融合,可以实现H'链分泌的拯救,MPC 11只合成轻链。杂交细胞(X-2)以四链结构(κ2α'2)分泌H'链。在野生型MOPC 315细胞中,先前有报道称抑制核心糖添加会阻断重链多肽的分泌。我们研究了MOPC 315野生型、LV-1变异株和X-2杂交细胞系中的糖基化。证实了所有这三个细胞系都有能力将核心糖甘露糖和葡糖胺添加到重链上。由于LV-1中H'链的不稳定性,直接评估H'链的岩藻糖基化很困难。为了研究LV-1中的岩藻糖添加,利用了可感染这三个细胞系的包膜病毒水疱性口炎病毒(VSV)。在所有这三个细胞系中都可辨别VSV糖蛋白G的岩藻糖基化和分泌;然而,只有LV-1不能激活游离岩藻糖,而是通过甘露糖中间体的转化进行岩藻糖基化。野生型细胞中重链正常的岩藻糖添加发生在分泌前不久。LV-1中H'链在岩藻糖基化之前就开始降解这一事实表明,通过形成X-2杂交细胞拯救H'链分泌是由于获得了合适的轻链,而不是糖缺陷的互补。这些观察结果表明,某些分泌蛋白(如Ig分子)的多肽成分的正确组装是单个链分泌所必需的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验